Track record · closed signal

Novo Nordisk A/S (NVO) — closed signal from June 11, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on September 9, 2026 — +2.4% at the close.

Predicted vs. what happened

NVO price · publication thesis → realized outcomesplit-adjusted
$43.51 Published $46.83 Target $44.56 Window close $51.46 Peak
$41.44 – $43.39Entry zone — fair-value band
$43.51Published — price the day we called it
$46.83Target — the price the thesis aimed for
$51.46Peak — highest point inside the window, not a realized return
$44.56Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 14 days.

At window close
+2.4%
realized, from the publication price to the last close inside the window
Peak gain
+18.3%
peak, from the publication price — not a realized return
S&P 500, same window
+3.6%
SPY over the identical days, dividend-adjusted
Window close
$44.56
last close inside the window, ended September 9, 2026
Peak price
$51.46
peak on July 29, 2026 — not a realized return
Days to target
14

The thesis — published June 11, 2026

Predicted growth
+9%
over the measurement window
Target price
$46.83
the price the thesis aimed for
Entry zone
$41.44 – $43.39
the fair-value band we waited for
Price at publication
$43.51
published June 11, 2026
Confidence
76%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Novo Nordisk is a steady healthcare company because many people need its diabetes and obesity medicines and the business makes good profit. Recent headlines- a cybersecurity breach and employers rethinking obesity-drug coverage-could make investors cautious short term. For the next few months the focus is on protecting value until sentiment steadies.

Primary drivers

  • Consistent demand for diabetes and obesity treatments supports steady sales
  • Acts as a defensive stock when markets are uncertain
  • Cybersecurity incident could hurt sentiment in the near term
  • Employer reviews of coverage may slow the stock's re-rating

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All NVO signals